Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningBone Marrow TransplantationHematologic NeoplasmsHematopoietic Stem Cell MobilizationStem CellsTreatment OutcomeGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsTissue DonorsTransplantation ChimeraLeukapheresisBusulfanImmunosuppressive AgentsGraft SurvivalMyeloablative AgonistsAntigens, CD34RecurrenceCombined Modality TherapyMelphalanMultiple MyelomaRemission InductionGraft vs Leukemia EffectBlood Component RemovalVidarabineCord Blood Stem Cell TransplantationHistocompatibility TestingCyclophosphamideCytomegalovirus InfectionsHistocompatibilityAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesWhole-Body IrradiationLeukemiaGraft vs Tumor EffectSalvage TherapyLeukemia, Myeloid, AcuteDisease-Free SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival RateSurvival AnalysisLymphocyte TransfusionLymphocyte DepletionTime FactorsSiblingsLymphoma, Non-HodgkinMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaAnemia, AplasticNeoplasm, ResidualAntilymphocyte SerumHematologic DiseasesEmbryonic Stem CellsCytomegalovirusEtoposideT-LymphocytesImmunocompromised HostAcute DiseaseInfectionOpportunistic InfectionsVirus ActivationCytarabineBlood CellsFollow-Up StudiesHodgkin DiseaseAdult Stem CellsMesenchymal Stem Cell TransplantationHLA AntigensHepatic Veno-Occlusive DiseaseMinor Histocompatibility AntigensChimerismBlood DonorsKidney TransplantationHematopoiesisImmunosuppressionBlood Cell CountLeukocyte TransfusionFlow CytometryAntineoplastic Agents, AlkylatingTransplantationTransplantation ImmunologyFatal OutcomeThiotepaPrognosisTransplantation, IsogeneicCyclosporineLiver TransplantationAntineoplastic AgentsRoseolovirus InfectionsLeukemia, MyeloidLymphomaGanciclovirBone Marrow CellsBone Marrow PurgingProspective Studies